NCT01735630 Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01734395 A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's Disease Status COMPLETED Phase N/A
NCT01730430 Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD Dementias Status COMPLETED Phase N/A
NCT01729598 Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study Status COMPLETED Phase EARLY_PHASE1
NCT01724151 Effects of Exercise Training in Patients With Mild Cognitive Impairment Status COMPLETED Phase N/A
NCT01723826 A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab Status COMPLETED Phase PHASE2
NCT01723670 Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment Status WITHDRAWN Phase PHASE2
NCT01716897 An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption Status COMPLETED Phase PHASE1
NCT01716637 Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT01715350 Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01712074 Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil Status TERMINATED Phase PHASE2
NCT01708304 Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs) Status COMPLETED Phase NA
NCT01703702 Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline Status COMPLETED Phase PHASE4
NCT01702480 Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects Status COMPLETED Phase PHASE1
NCT01702467 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers Status COMPLETED Phase PHASE1